Esranur Aydın

机构：Precision for Medicine (United States), Istinye University · ORCID：0000-0001-7850-0177

发表论文 19 篇 · 总被引 66 次 · h-index 5

代表论文

• Cytotoxic Activity and Docking Studies of 2-arenoxybenzaldehyde N-acyl Hydrazone and 1,3,4-Oxadiazole Derivatives against Various Cancer Cell Lines (2022 · Molecules · 被引 19)
• PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview (2023 · Therapeutic Advances in Medical Oncology · 被引 9)
• Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview (2023 · JCO Precision Oncology · 被引 8)
• Therapeutic vulnerabilities and pan-cancer landscape of BRAF class III mutations in epithelial solid tumors (2024 · BJC Reports · 被引 7)
• Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers (2024 · Current Oncology · 被引 5)
• Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety (2024 · Therapeutic Advances in Medical Oncology · 被引 5)